OverviewBiotechnology - striking it rich in Asia
Biotechnology has become one of the most important areas of science for the 21st century. Justin Davidson, Connie Carnabuci and Grace Tan consider the potential for developing and promoting biotechnology in Asia, focusing in particular on China - one of the most important emerging economies in Asia
Three key factors determine the attractiveness of a country to a
potential biotechnology investor: the intellectual property rights
regime and the scope of protection for biotechnology inventions
(their patentability); the bio-ethical regulatory environment; and
the active support and promotion of this industry by government and
national organizations.
Patentability
From a prospective investor's point of view, given the millions
of dollars of capital investment involved in research and
development in biotechnology, a major concern will be ensuring that
there is an acceptable return on investment. Critical in securing
this return, is ensuring that the investor secures the exclusive
right to exploit commercially the end product or invention
resulting from the R&D effort. This will in turn be dependent
on the intellectual property rights arising in the product or
invention. Confirming that the relevant IP regime provides patent
protection for the invention is vital.
For an invention to be patentable, it...
Only subscribers have complete access to Managing IP Magazine,
log in or
subscribe now.
Alternatively take a
free trial, giving you 48-hour access to Managing IP Magazine (some articles and surveys may be excluded).
Subscribe Now
This article is available to subscribers. Please click subscribe to read the rest of the article.
Subscribe
Take a free trial
Please take a free 48-hour trial to gain limited access. Some articles and surveys may be excluded.
Take a free trial